Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
SN

Smith & Nephew plc

SNLSEUnited KingdomHealthcareMedical DevicesFTSE 100

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

P/E20.12xP/B2.38xROIC8.3%Dividend yield2.7%
£9.09B
Market Cap
EV: £12.29B
MOM2
QUAL7
VAL7
RSK3
SN
£9.09B
Market Cap · EV £12.29B

Smith & Nephew plc

MOM2
QUAL7
VAL7
RSK3

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

Latest RNS from Smith & Nephew plc

Analyst consensus: Hold

As of 10 Nov 2026, 18 analysts rate Smith & Nephew plc a Hold, with 22% buy ratings and a mean price target of 1,232p (range 1,024p–1,435p), +8% vs the current price.

Strong buy: 1Buy: 3Hold: 13Sell: 0Strong sell: 1

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 1,993p against a current price of 1,144p (+74%), based on EV/EBITDA.

More Healthcare companies